Aceso Life Science Group (SEHK:474) Balance Sheet Analysis 2004-2025

Socials

NEWSLETTER

View Data Providers

NEWSLETTER

View Data Providers

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

Metric	2023	2024	LTM
Total Cash And Short-Term Investments	HK$466M	HK$207M	HK$330M
Net Receivables	HK$764M	HK$297M	-
Inventory	HK$2M	HK$2M	-
Prepaid Expenses And Other Current Assets	HK$13M	HK$7M	-
Other Current Assets	HK$20M	HK$17M	HK$-330M
Total Current Assets	HK$1.265B	HK$0.53B	-
Property, Plant And Equipment	HK$253M	HK$174M	HK$21M
Goodwill And Intangible Assets	HK$497M	HK$350M	-
Long-Term Investments	HK$3M	-	-
Deferred Tax Assets	HK$58M	HK$7M	HK$7M
Other Noncurrent Assets	HK$2.71B	HK$2.182B	HK$-0.028B
Total Noncurrent Assets	HK$3.521B	HK$2.713B	-
Other Assets	-	-	HK$1.722B
Total Assets	HK$4.786B	HK$3.243B	HK$1.722B

Metric	2023	2024	LTM
Total Payables	HK$109M	HK$137M	-
Accrued Expenses	HK$57M	-	-
Short-Term Debt	HK$2.053B	HK$1.714B	HK$0.105B
Current Portion Of Lease Obligations	HK$10M	HK$11M	-
Income Taxes Payable	HK$16M	HK$19M	-
Current Deferred Revenue	-	-	-
Other Current Liabilities	HK$-15M	HK$44M	HK$-105M
Total Current Liabilities	HK$2.214B	HK$1.906B	-
Long-Term Debt	HK$0.657B	HK$0.546B	HK$1.097B
Capital Lease Obligations	HK$19M	HK$26M	-
Noncurrent Deferred Revenue	-	-	-
Noncurrent Deferred Tax Liabilities	HK$84M	HK$17M	-
Other Noncurrent Liabilities	-	-	HK$-1.1B
Total Noncurrent Liabilities	HK$759M	HK$593M	-
Other Liabilities	-	-	HK$1.352B
Total Liabilities	HK$2.973B	HK$2.499B	HK$1.352B

Metric	2023	2024	LTM
Treasury Stock	HK$-13M	HK$-26M	-
Preferred Stock	-	-	-
Common Stock	HK$73M	HK$73M	HK$73M
Retained Earnings	HK$-3.443B	HK$-4.338B	-
Additional Paid-In Capital	HK$4.811B	HK$4.811B	-
Accumulated Other Comprehensive Income	HK$-507M	-	-
Other Stockholders' Equity	-	HK$-508M	HK$298M
Total Common Stockholders' Equity	HK$921M	HK$12M	HK$371M
Minority Interest	HK$892M	HK$732M	HK$-1M
Total Equity	HK$1.813B	HK$0.744B	HK$0.37B
Total Liabilities And Equity	HK$4.786B	HK$3.243B	HK$1.722B

Metric	2023	2024	LTM
Total Investments	HK$119M	HK$75M	HK$143M
Total Debt	HK$2.738B	HK$2.301B	HK$1.205B
Net Debt	HK$2.369B	HK$2.169B	HK$1.018B

Aceso Life Science Group
474

Balance Sheet

Balance Sheet Composition

Aceso Life Science Group 474

Balance Sheet

Balance Sheet Composition

Aceso Life Science Group
474